Digital Library
Close Browse articles from a journal
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             59 results found
no title author magazine year volume issue page(s) type
1 A cell-based model to study mechanisms of endothelial-dependent thrombin generation in response to inflammation and its modulation by hydroxychloroquine Arachchillage, Deepa J.

9 1 p.
article
2 Acquired factor V inhibitor in a case of pediatric venous thrombosis Gupta, Sweta

9 1 p.
article
3 Adeno-associated virus-based gene therapy for hemophilia–addressing the gaps Miesbach, Wolfgang

9 1 p.
article
4 A literature review of major surgery experience with emicizumab in people with hemophilia A without factor VIII inhibitors Castaman, Giancarlo

9 1 p.
article
5 Altered clot structure in pregnant women who will develop postpartum hemorrhage de Moreuil, Claire

9 1 p.
article
6 Andexanet alfa: trials just leave us with more questions Buka, Richard J.

9 1 p.
article
7 Anticoagulant management of cancer-associated thrombosis and thrombocytopenia: a retrospective chart review Abbas, Umaima

9 1 p.
article
8 Beyond platelet activation: dysregulated lipid metabolism in defining risk and pathophysiology of VITT Stevens, Hannah

9 1 p.
article
9 Carbon dioxide alleviates platelet storage lesions via stimulating fatty acid metabolism and reducing platelet glucose consumption Gu, Shunli

9 1 p.
article
10 Challenges and considerations of genetic testing in von Willebrand disease Seidizadeh, Omid

9 1 p.
article
11 Changes in platelet maturity and reactivity following acute ST-segment elevation myocardial infarction Pedersen, Oliver Buchhave

9 1 p.
article
12 Characterization of bleeding in thrombotic thrombocytopenic purpura in the precaplacizumab era: a retrospective nationwide analysis Mahmoud, Amir A.

9 1 p.
article
13 Characterization of the procoagulant phenotype of amniotic fluid across gestation in rhesus macaques and humans Yang, Chih Jen

9 1 p.
article
14 Clinical management of bleeding manifestations in a family with the thrombomodulin C1611>A (p.Cys537Stop) mutation Pierre-Louis, Serge

9 1 p.
article
15 Comparative analyses of the hemostatic efficacy and surgical device performance of powdered oxidized regenerated cellulose and starch-based powder formulations Stark, Marianne

9 1 p.
article
16 Contemporary approaches to treat people with hemophilia: what’s new and what’s not? Valentino, Leonard A.

9 1 p.
article
17 Editorial Board
9 1 p.
article
18 Effect of plasma levels of factor VIII according to procoagulant phospholipids on the risk of future venous thromboembolism Edvardsen, Magnus S.

9 1 p.
article
19 Extending health equity to people with moderate and mild hemophilia A: revisiting the HAVEN 6 trial Hermans, Cedric

9 1 p.
article
20 External validation of a novel cancer-associated venous thromboembolism risk assessment score in a safety-net hospital Dulberger, Karlynn N.

9 1 p.
article
21 Gene therapy in hemophilia: the dawn of a new era Gualtierotti, Roberta

9 1 p.
article
22 Global prevalence of platelet-type von Willebrand disease Seidizadeh, Omid

9 1 p.
article
23 Health literacy in pediatric thrombosis: a landscape analysis Bastas, Denise

9 1 p.
article
24 Histologic evidence of neutrophil extracellular traps and fibrin(ogen) deposition in liver biopsies from patients with inflammatory liver disease von Meijenfeldt, Fien A.

9 1 p.
article
25 Immune tolerance induction for inhibitor eradication in nonsevere hemophilia A: a case series Nusrat, Sanober

9 1 p.
article
26 Impact of antiplatelet therapy on hemostatic plug formation in the setting of thrombocytopenia Lee, Robert H.

9 1 p.
article
27 Intermediate-dose immune tolerance induction outperforms with faster success, less bleeding, and no added cost in comparison with low dose: a multicenter randomized clinical trial Li, Zhengping

9 1 p.
article
28 Intrinsic pathway activation in patients with antiphospholipid syndrome and healthy controls van Mourik, Dagmar J.M.

9 1 p.
article
29 Investigating tissue factor pathway inhibitor and other protease and protease inhibitors and their association with major adverse aortic events in patients with abdominal aortic aneurysm Khan, Hamzah

9 1 p.
article
30 Janus kinase inhibitor treatment for inflammatory diseases: excess or no excess risk of venous thromboembolism? Dawudi, Yachar

9 1 p.
article
31 Management of patients with venous thromboembolism and a high recurrence risk estimated by the Vienna Prediction Model: a prospective cohort study Šinkovec, Hana

9 1 p.
article
32 Measurement of factor XIII for the diagnosis and management of deficiencies: insights from a retrospective review of 10 years of data on consecutive samples and patients Al Sharif, Mohammed Abdullah

9 1 p.
article
33 Mini-clusters of postadenovirus VITT Lambert, Michele P.

9 1 p.
article
34 No correlation between thrombin generation and emicizumab levels: implications for monitoring emicizumab therapy van der Zwet, Konrad

9 1 p.
article
35 Occurrence and management of thrombosis recurrence and bleeding in low-molecular-weight heparin-treated patients with cancer-associated thrombosis: a French nationwide cohort study Mahé, Isabelle

9 1 p.
article
36 Plasma microRNA-145-5p as a diagnostic biomarker for acute deep vein thrombosis Antoun, Christopher

9 1 p.
article
37 Preemptive anticoagulation during antenatal pulmonary embolism diagnostics in a community setting: retrospective cohort study Campbell, Aidan R.

9 1 p.
article
38 Prevalence and clinical impact of disseminated intravascular coagulation in acute aortic dissection: a nationwide cohort study Murao, Shuhei

9 1 p.
article
39 Prophylactic use of recombinant ADAMTS-13 during pregnancy for congenital thrombotic thrombocytopenic purpura Colliou, Éloïse

9 1 p.
article
40 Real-world andexanet alfa utilization and the association between delay in administration due to hospital transfer and all-cause inpatient mortality Fan, Huiqiao

9 1 p.
article
41 Recombinant factor VIIa: new insights into the mechanism of action through product innovation Escobar, Miguel A.

9 1 p.
article
42 Reduced- versus full-dose anticoagulants for the extended treatment of cancer-associated venous thromboembolism in Thai patients Vichaidit, Kawin

9 1 p.
article
43 Relevance of anti–platelet factor 4/heparin antibodies and platelet activation in systemic inflammatory diseases and thrombosis disorders: insight from the COVID-19 pandemic Gendron, Nicolas

9 1 p.
article
44 Risk assessment and prevention of cancer-associated venous thromboembolism in ambulatory patients with solid malignancies Vladic, Nikola

9 1 p.
article
45 Sex-specific cut-off for dilute Russell’s viper venom time lupus anticoagulant test may be of value Tang, Ning

9 1 p.
article
46 Should a history of venous thromboembolism be considered a contraindication for scuba diving? Vannini, Mathilde

9 1 p.
article
47 Silencing of the von Willebrand factor gene in proatherothrombotic APOE∗3-Leiden.CETP transgenic mice Jongejan, Yvonne K.

9 1 p.
article
48 Structural bioinformatics for rational drug design Mozaffari, Soroush

9 1 p.
article
49 The detrimental impact of ferritin “normal” ranges on diagnosis of bleeding disorders in women Sholzberg, Michelle

9 1 p.
article
50 The Functional Characterization of Venous Thromboembolic Disease (FUVID) study: rationale, design, and methods of a prospective, observational, multicenter study to evaluate mechanisms of exercise intolerance and dyspnea following pediatric pulmonary embolism Zia, Ayesha

9 1 p.
article
51 The risk for psychiatric disorders in offspring from thrombosis-prone pedigrees in Sweden: a nationwide family study Zöller, Bengt

9 1 p.
article
52 Thromboprophylaxis in multiple myeloma Frenzel, Laurent

9 1 p.
article
53 Time trends of catheter-directed treatment in acute pulmonary embolism in Germany Keller, Karsten

9 1 p.
article
54 Transcription factor RUNX1 regulates coagulation factor XIII-A (F13A1): decreased platelet-megakaryocyte F13A1 expression and clot contraction in RUNX1 haplodeficiency Del Carpio-Cano, Fabiola

9 1 p.
article
55 Transfusion in trauma: empiric or guided therapy? Barrett, Liam

9 1 p.
article
56 Trenonacog alfa safety, efficacy, and pharmacokinetics in previously treated pediatric hemophilia B Vilchevska, Kateryna

9 1 p.
article
57 Type of D-dimer assay determines the diagnostic yield of computed tomography in patients suspected for pulmonary embolism Assmann, Jorn L.J.C.

9 1 p.
article
58 Validation of the 5-SNP score for the prediction of venous thromboembolism in a Danish fast-track cohort of 6789 total hip and total knee arthroplasty patients Smeets, Mark J.R.

9 1 p.
article
59 Venous thromboembolism still leads on maternal death Shard, Amelia

9 1 p.
article
                             59 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands